Controlling Polysorbate Degradation
Cloud-Native Drug Discovery
Early-Phase Oncology Trials Shaping the Future of Cancer Research
Tailored Artificial Intelligence (AI)
Accelerating Cross-Sector Integration in Pharma and Nutraceuticals
EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Compliance to Competitive Advantage in Pharma Supply
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
.webp)
KNOWLEDGE BANK
-
Articles
Optimizing Pharmaceutical Viral Vector Production: Techniques and Challenges
Pharmaceutical viral vectors have emerged as powerful tools in gene therapy vaccine development and biotechnology research The ability of viral vectors to deliver genetic material into target cells
Next-Gen Continuous Biomanufacturing: Redefining Efficiency and Quality Standards
Continuous biomanufacturing represents a paradigm shift in the production of biopharmaceuticals offering unparalleled efficiency flexibility and quality control compared to traditional batch processes
Bispecific Antibodies: Transforming the Future of Oncology
For two decades bispecific antibodies occupied an awkward position in pharmaceutical oncology strategy scientifically compelling commercially unproven and persistently difficult to manufacture That characterisation no longer holds Nineteen bispecific antibodies have been approved globally and combined sales of the class passed twelve billion dollars in with several products now anchoring
Pharma Event Marketing in Europe: Virtual & Hybrid Strategies to Drive High-Quality Leads
It is likely that you have attended some pharma event recently say in Frankfurt or Basel or even online and have noticed one thing Nothing wants lack of activity Booths are busy Webinars get registrations Virtual platforms show decent attendance numbers But when the dust settles a familiar problem shows up again
The Integration of Genomics into European Drug Development: Advances and Implications
Genomics in which genes and their novelty are discovered and taken into account as tools has recently risen as a strong tool in the drug discovery process Applying genomics into drug development in Europe has therefore provided a way towards more effective and safer drugs In light of the present analysis this article addresses how genomics is transforming drug development in Europe and its benefit...
How Good Clinical Practice (GCP) Compliance Shapes Pharma Success?
Good Clinical Practice GCP compliance is a cornerstone of pharmaceutical research and development ensuring that clinical trials are conducted ethically with participant safety as the top priority
-
Techno Trends
Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein
Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue
-
Projects
SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing
SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more
-
Research Insights
A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG
PIGACDG is a congenital disorder of glycosylation caused by pathogenic partial lossoffunction variants in the PIGA gene PIGA encodes an enzyme responsible for the catalytic transfer of Nacetylglucosamine
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
Next-Gen Continuous Biomanufacturing: Redefining Efficiency and Quality Standards
Kate Williamson
Explore the transformative realm of next-gen continuous biomanufacturing, revolutionizing biopharmaceutical production with efficiency, quality control, and flexibility. Uncover key components, benefi...
-
2
Bispecific Antibodies: Transforming the Future of Oncology
Lakshmi
Bispecific antibodies have moved from concept to commercial reality, with a growing set of approvals and multi-billion-euro sales concentrated in haematology. The strategic contest now shifts to solid...
-
3
Pharma Event Marketing in Europe: Virtual & Hybrid Strategies to Drive High-Quality Leads
Kate Williamson
In Europe, pharma event marketing is becoming more data-driven, hybrid, and digital-first. In the case of virtual webinars to trade show, engagement quality and not quantity now determines success. Th...
-
4
The Integration of Genomics into European Drug Development: Advances and Implications
Harry Callum
Some applications of genomics are the modernization of drug discovery in Europe, individualized treatments by patients, and administrative assists in clinical trials. In targeted therapies and more pr...
-
5
How Good Clinical Practice (GCP) Compliance Shapes Pharma Success?
Kate Williamson
Explore how Good Clinical Practice (GCP) Compliance drives ethical conduct, participant safety, data integrity, and regulatory adherence in pharmaceutical research. Discover its impact on drug develop...
press releases Read more...
Laboratoires Pierre Fabre and XtalPi Announce an AI-Driven Collaboration Focused on Drug Discovery
Laboratoires Pierre Fabre and XtalPi are pleased to announce an agreement under which they will collaborate on the discovery of novel clinical candidates across a number of research programs in the field of oncology potentially dermatology and rare diseases
Essential Pharma and Nordmark announce new partnership and UK availability of Norzyme® (pancreas powder) 25,000 gastro-resistant capsules for pancreatic exocrine insufficiency
Essential Pharma Limited a UKheadquartered specialty pharmaceutical company focused on specialty care and rare disease and Nordmark Pharma GmbH Nordmark a Germanheadquartered pharmaceutical company focused on developing and manufacturing active ingredients and medicines
Sino Biological Advances AI-Designed Molecule Validation with 4RISE™
AI can generate protein candidates at an unprecedented speed but experimental validation remains essential to determine whether they properly express bind targets and demonstrate the desired biological properties Sino Biological Inc Shenzhen Stock Exchange SZ a global leader in recombinant protein t...
Biocodex Invests €15 Million in a New Industrial Platform for Live Biotherapeutic Products
Biocodex an independent French pharmaceutical company announces a million investment to develop an industrial platform in Beauvais France dedicated to Live Biotherapeutic Products LBPs derived from the microbiome Building on more than years of expertise in living microorganisms microbiota fermenta...
Events Read more...
09 - 11
Nov 202611th Microbiome Movement USA Summit
The Colonnade Hotel, Boston, M...
10 - 11
Nov 2026Extractables & Leachables Europe
Parkhotel Schӧnbrunn, Vienna,...
11 - 13
Nov 2026Frontiers in Cancer Science 2026
One Farrer Hotel,1 Farrer Park...
11 - 12
Nov 2026Medical Device Project and Portfolio Management
Chicago, IL, USA
16 - 17
Nov 2026Analytics for Smarter Decisions in Pharma
London, UK
24 - 27
Nov 2026Pharmtech & Ingredients 2026
Crocus Expo, Pavilion 2, Mosco...
24 - 25
Nov 2026BioPharma Deals Conference 2026
Science Congress Center, Munic...
25 - 25
Nov 2026What’s Next for Pharma Marketing in 2027
Landesmuseum Zürich, Zurich, S...
LATEST NEWS Read more...
Oncovita Granted Orphan Drug Designation For MVdeltaC in Mesothelioma by the European Commission
Oncovita a French biotechnology company specialized in therapeutic and prophylactic vaccines today announced that the European Commission has granted orphan medicinal product designation to its lead investigational candidate MVdeltaC for the treatment of mesothelioma
DeepLife and 3billion partner to discover small-molecule therapeutics against genetic modifier targets across multiple diseases
DeepLife a Parisbased techbio company developing AIpowered digital twins of human cells and billion an AIpowered genomics company specializing in rare disease diagnostics and drug discovery today announced a codevelopment collaboration to discover and develop new smallmolecule therapeutics
Portal Innovations and Altitude Lab Partner to Strengthen Utah’s Life Sciences Startup Ecosystem
Portal Innovations a venture development platform supporting earlystage life sciences companies today announced a strategic partnership with Altitude Lab to strengthen the resources available to life sciences entrepreneurs in Salt Lake City Through the partnership Altitude Lab will relocate its acce...
MRM Health and Biocodex establish strategic partnership to strengthen future commercial supply capabilities for CORAL®-based medicines
MRM Health a clinicalstage biotech developing microbiomebased therapies for immunemediated diseases and Biocodex an independent French pharmaceutical company with more than years of experience in the microbiome field today announced the launch of a strategic partnership to establish specialized man...
Breakthrough Therapy Designation granted by the FDA for daridorexant in pediatric insomnia disorder
Idorsia Ltd announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to daridorexant for the treatment of insomnia disorder in patients to
Evestia Clinical Acquires Emtex Life Science to Further Enhance its Global Full-Service Clinical Research Capabilities
Evestia Clinical a leading independent global specialist Contract Research Organization CRO today announced the acquisition of Emtex Life Science Emtex a specialist regulatory medical writing company headquartered in Belgium The acquisition strengthens Evestia
